Every time I get the right treatment at the right time, it is the heart of all patients, and the ultimate goal of precision medicine . Zhongshan Hospital affiliated to Dalian University has been the first to explore the MDT diagnosis and treatment model of gastrointestinal tumors in Dalian since 2009. It can be said that this is a good start for the accurate diagnosis and treatment of gastrointestinal tumors. However, to develop a personalized medical plan based on the characteristics of each individual, it is necessary to understand a person as much as possible, and also rely on genetic testing. In 2013, Zhongshan Hospital affiliated to Dalian University introduced Dr. Ding Yan, a thousand-level talent in the “Ten Thousand High-end Introduced Talent Project†of Liaoning Province, as the founder of the American Institute of Genetic Translation Medicine and the Harvard Joint Laboratory Joint Laboratory of the American Institute of Genetic Translation Medicine. Director, Dr. Ding Yan independently developed the cancer-specific biomarker and new drug target system OncoDecoder (data analysis system) and obtained US patents. Under the leadership of Dr. Ding Yan, Zhongshan Hospital affiliated to Dalian University and the Harvard Joint Laboratory of the American Institute of Genetic Translation Medicine have established the China-US Institute of Genetic Translation Medicine, which will bring more cancer patients under the new concept of precision medicine. Quality international medical services. Staff genetic sequencing work 　　 Staff conduct genetic testing related work 　　 Professor Ding Yan guides the work 　　 Lung nodules MDT treatment group is reading Sino-US Institute of Genetic Translational Medicine - Deciphering "Life Code" Leading Precision Medicine A gene is a DNA sequence that contains a genetic code and transmits genetic information with certain biological functions. It not only determines a person's physical appearance, personality characteristics, but also closely related to many diseases. With the advancement of human genome sequencing technology, the success rate of disease diagnosis and treatment is getting higher and higher. The emergence of big data analysis tools has the ability to store and analyze genetic data on a large scale. Accurate medical care is taking place and moving forward. To this end, the Zhongshan University Hospital of Dalian University established the Sino-US Translational Medicine Institute to conduct molecular analysis through genome-wide sequencing, exome sequencing, target gene sequencing, peripheral blood circulation tumor cell detection, breast cancer 21 gene + chemotherapy drug detection, etc. Research and development and clinical application of pathology, genetic diagnosis, translational medicine, and individualized treatment of cancer, and conduct early cancer diagnosis, birth defect diagnosis, genetic disease screening, reproductive health screening, and drug safety and efficiency improvement projects. YT-60 YT-60 Shenzhen Sunshine Technology Co.,Ltd , https://www.szyatwin.com
